The study found that anti-Müllerian hormone (AMH) levels and total follicle count were significantly lower in vitiligo patients compared to healthy controls, and one case of premature ovarian failure (POF) was identified in the vitiligo group, which differed significantly from the healthy controls (21). The gene discussed is AMH; the disease is premature menopause.